PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 186 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,361,000 | +26.3% | 84,397 | +95.6% | 0.14% | +24.8% |
| Q2 2015 | $5,037,000 | -42.4% | 43,141 | +16.4% | 0.11% | -40.4% |
| Q1 2015 | $8,749,000 | +700.5% | 37,052 | +541.3% | 0.18% | +662.5% |
| Q4 2014 | $1,093,000 | -13.9% | 5,778 | +8.5% | 0.02% | -14.3% |
| Q3 2014 | $1,270,000 | -1.1% | 5,323 | -72.6% | 0.03% | 0.0% |
| Q2 2014 | $1,284,000 | +3.8% | 19,461 | +63.8% | 0.03% | +3.7% |
| Q1 2014 | $1,237,000 | -25.8% | 11,879 | -26.2% | 0.03% | -22.9% |
| Q4 2013 | $1,666,000 | – | 16,088 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |